192 related articles for article (PubMed ID: 3254259)
21. The role of HLA antigens in the manifestation and course of Graves' disease.
Stenszky V; Kozma L; Balazś C; Bear JC; Farid NR
Mol Biol Med; 1986 Feb; 3(1):53-62. PubMed ID: 3485758
[TBL] [Abstract][Full Text] [Related]
22. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay.
Ahmann A; Baker JR; Weetman AP; Wartofsky L; Nutman TB; Burman KD
J Clin Endocrinol Metab; 1987 Mar; 64(3):454-60. PubMed ID: 2434519
[TBL] [Abstract][Full Text] [Related]
23. Analysis of HLA-DQB and HLA-DPB alleles in Graves' disease by oligonucleotide probing of enzymatically amplified DNA.
Weetman AP; Zhang L; Webb S; Shine B
Clin Endocrinol (Oxf); 1990 Jul; 33(1):65-71. PubMed ID: 2401099
[TBL] [Abstract][Full Text] [Related]
24. Graves' ophthalmopathy, eye muscle antibodies and HLA antigens.
Balazs C; Bokk A; Molnar I; Stenszky V; Farid NR
Exp Clin Immunogenet; 1989; 6(2):190-2. PubMed ID: 2629892
[No Abstract] [Full Text] [Related]
25. Immunogenetic markers in patients with Graves' disease.
Schifferdecker E; Kühnl P; Schöffling K; Manfras B; Holzberger G; Spielmann W; Böhm BO
Klin Wochenschr; 1991 Apr; 69(6):256-60. PubMed ID: 2038175
[TBL] [Abstract][Full Text] [Related]
26. UCLA conference. Autoimmune thyroid diseases--Graves' and Hashimoto's.
Ann Intern Med; 1978 Mar; 88(3):379-91. PubMed ID: 204241
[TBL] [Abstract][Full Text] [Related]
27. Thyroid-stimulating antibodies in patients with autoimmune disorders.
Strakosch CR; Joyner D; Wall JR
J Clin Endocrinol Metab; 1978 Aug; 47(2):361-5. PubMed ID: 263731
[TBL] [Abstract][Full Text] [Related]
28. Serological and molecular studies of HLA in Sardinian patients with Graves' disease.
La Nasa G; Martino E; Carcassi C; Mulargia M; Floris L; Vacca A; Baldini G; Orrù S; Ledda A; Grasso L
Dis Markers; 1991; 9(6):307-12. PubMed ID: 1823309
[TBL] [Abstract][Full Text] [Related]
29. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR
J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139
[TBL] [Abstract][Full Text] [Related]
30. Reduced C4 in HLA-B8 positive patients with Graves' disease.
Tom W; Farid NR
Hum Hered; 1981; 31(4):227-31. PubMed ID: 6895210
[TBL] [Abstract][Full Text] [Related]
31. HLA antigens in Greek patients with thyrotoxicosis (Graves' disease and toxic nodular goiter).
Papasteriades C; Alevizaki-Harhalaki MN; Economidou J; Ikkos DG
J Endocrinol Invest; 1984 Aug; 7(4):283-6. PubMed ID: 6594386
[TBL] [Abstract][Full Text] [Related]
32. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
Zhang Q; Yang YM; Lv XY
J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303
[TBL] [Abstract][Full Text] [Related]
33. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Tomer Y; Davies TF
Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
[TBL] [Abstract][Full Text] [Related]
34. Human leukocyte antigens associated with hyperthyroid Graves ophthalmology in Japanese patients.
Ohtsuka K; Nakamura Y
Am J Ophthalmol; 1998 Dec; 126(6):805-10. PubMed ID: 9860004
[TBL] [Abstract][Full Text] [Related]
35. Significance of HLA in the development of Graves' orbitopathy.
Stasiak M; Zawadzka-Starczewska K; Tymoniuk B; Stasiak B; Lewiński A
Genes Immun; 2023 Feb; 24(1):32-38. PubMed ID: 36639701
[TBL] [Abstract][Full Text] [Related]
36. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism.
Kotsa K; Watson PF; Weetman AP
Clin Endocrinol (Oxf); 1997 May; 46(5):551-4. PubMed ID: 9231050
[TBL] [Abstract][Full Text] [Related]
37. Graves' disease and HLA: clinical and epidemiologic associations.
Farid NR; Stone E; Johnson G
Clin Endocrinol (Oxf); 1980 Dec; 13(6):535-44. PubMed ID: 6894412
[TBL] [Abstract][Full Text] [Related]
38. A study of human leukocyte D locus related antigens in Graves' disease.
Farid NR; Sampson L; Noel EP; Barnard JM; Mandeville R; Larsen B; Marshall WH; Carter ND
J Clin Invest; 1979 Jan; 63(1):108-13. PubMed ID: 105012
[TBL] [Abstract][Full Text] [Related]
39. HLA DQA1*0501 and DRB1*0301 antigens do not independently convey susceptibility to Graves' disease.
Philippou G; Krimitzas A; Kaltsas G; Anastasiou E; Souvatzoglou A; Alevizaki M
J Endocrinol Invest; 2001 Feb; 24(2):88-91. PubMed ID: 11263477
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and nonthyroid diseases.
Wu YJ; Clarke EM; Shepherd P
Thyroid; 1998 Feb; 8(2):167-74. PubMed ID: 9510126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
